BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Apollomics Announces Presentation at the 2024 BIO International Convention

  Apollomics Inc. announced that the Company will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, California.

  May 29, 2024

   · 

  1 min read
• BioMidwest

  VolitionRx Limited to Present at Jefferies 2024 Global Healthcare Conference

  VolitionRx Limited, a multi-national epigenetics company, announced that Cameron Reynolds, President and Group Chief Executive Officer, will present and be available for one-to-one meetings at the Jefferies Global Healthcare Conference in New York City.

  May 29, 2024

   · 

  1 min read
• Pharm Country

  Gameto Raises $33 Million in Series B Financing to Advance Development and Commercialization of Novel Fertility Treatments

  Gameto has closed an oversubscribed $33 million Series B financing round, led by Two Sigma Ventures with RA Capital and participation from existing investors, including Insight Partners, Future Ventures, and BOLD Capital Partners.

  May 29, 2024

   · 

  5 min read
• BioForest

  BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver

  BioLife Solutions, Inc., a leading supplier of bioproduction tools and services for the cell and gene therapy and broader biopharma markets, announced the introduction of the CryoCase, an addition to its CellSeal product line.

  May 29, 2024

   · 

  2 min read
• NewBiologix Launches Proprietary HEK293 Cell Line for the Expression of Viral Vectors Used in Gene Therapy

  NewBiologix SA, a technology innovation company focused on addressing gene and cell therapy manufacturing gaps, announced the launch of NBX-HEK293, the Company’s engineered host HEK293 cell line for the production of recombinant adeno-associated viruses used in gene therapy.

  May 29, 2024

   · 

  2 min read
• Business

  RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and Efficacy of CX1739

  RespireRx Pharmaceuticals Inc. is delighted to announce that the Department of Defense (DOD) has approved a $1.8 million translational research award to Shirley Ryan AbilityLab to fund a two stage Phase 2A and 2B clinical study.

  May 29, 2024

   · 

  15 min read
• Pharm Country

  Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day

  Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day.

  May 29, 2024

   · 

  14 min read
• Genetown

  enGene to Present at the Jefferies Global Healthcare Conference

  enGene Holdings Inc. today announced that Jason Hanson, Chief Executive Officer, will present a corporate overview at the Jefferies Global Healthcare Conference in New York City, on June 5, 2024, at 12:30 p.m. ET.

  May 29, 2024

   · 

  1 min read
• Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024

  Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024.

  May 29, 2024

   · 

  7 min read
• Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024

  Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced its participation in the Jefferies Healthcare Conference in New York on June 5-6, 2024.

  May 29, 2024

   · 

  2 min read